BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wall G, Chaturvedi AK, Wormley FL Jr, Wiederhold NP, Patterson HP, Patterson TF, Lopez-Ribot JL. Screening a Repurposing Library for Inhibitors of Multidrug-Resistant Candida auris Identifies Ebselen as a Repositionable Candidate for Antifungal Drug Development. Antimicrob Agents Chemother 2018;62:e01084-18. [PMID: 30104269 DOI: 10.1128/AAC.01084-18] [Cited by in Crossref: 41] [Cited by in F6Publishing: 25] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Nagy F, Vitális E, Jakab Á, Borman AM, Forgács L, Tóth Z, Majoros L, Kovács R. In vitro and in vivo Effect of Exogenous Farnesol Exposure Against Candida auris. Front Microbiol 2020;11:957. [PMID: 32508780 DOI: 10.3389/fmicb.2020.00957] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
2 Lara HH, Ixtepan-Turrent L, Jose Yacaman M, Lopez-Ribot J. Inhibition of Candida auris Biofilm Formation on Medical and Environmental Surfaces by Silver Nanoparticles. ACS Appl Mater Interfaces 2020;12:21183-91. [PMID: 31944650 DOI: 10.1021/acsami.9b20708] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
3 Billamboz M, Fatima Z, Hameed S, Jawhara S. Promising Drug Candidates and New Strategies for Fighting against the Emerging Superbug Candida auris. Microorganisms 2021;9:634. [PMID: 33803604 DOI: 10.3390/microorganisms9030634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gnat S, Łagowski D, Dyląg M, Jóźwiak G, Trościańczyk A, Nowakiewicz A. In Vitro Activity of Ebselen and Diphenyl Diselenide Alone and in Combination with Drugs against Trichophyton mentagrophytes Strains. Pharmaceutics 2022;14:1158. [DOI: 10.3390/pharmaceutics14061158] [Reference Citation Analysis]
5 Wall G, Lopez-Ribot JL. Screening Repurposing Libraries for Identification of Drugs with Novel Antifungal Activity. Antimicrob Agents Chemother 2020;64:e00924-20. [PMID: 32660991 DOI: 10.1128/AAC.00924-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 de Oliveira HC, Monteiro MC, Rossi SA, Pemán J, Ruiz-Gaitán A, Mendes-Giannini MJS, Mellado E, Zaragoza O. Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen Candida auris. Front Cell Infect Microbiol 2019;9:83. [PMID: 31001487 DOI: 10.3389/fcimb.2019.00083] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
7 Kovács R, Majoros L. Fungal Quorum-Sensing Molecules: A Review of Their Antifungal Effect against Candida Biofilms. J Fungi (Basel) 2020;6:E99. [PMID: 32630687 DOI: 10.3390/jof6030099] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
8 Beattie SR, Krysan DJ. Antifungal drug screening: thinking outside the box to identify novel antifungal scaffolds. Curr Opin Microbiol 2020;57:1-6. [PMID: 32339892 DOI: 10.1016/j.mib.2020.03.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Arastehfar A, Gabaldón T, Garcia-Rubio R, Jenks JD, Hoenigl M, Salzer HJF, Ilkit M, Lass-Flörl C, Perlin DS. Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium. Antibiotics (Basel) 2020;9:E877. [PMID: 33302565 DOI: 10.3390/antibiotics9120877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Kim JH, Cheng LW, Chan KL, Tam CC, Mahoney N, Friedman M, Shilman MM, Land KM. Antifungal Drug Repurposing. Antibiotics (Basel) 2020;9:E812. [PMID: 33203147 DOI: 10.3390/antibiotics9110812] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
11 Atriwal T, Azeem K, Husain FM, Hussain A, Khan MN, Alajmi MF, Abid M. Mechanistic Understanding of Candida albicans Biofilm Formation and Approaches for Its Inhibition. Front Microbiol 2021;12:638609. [PMID: 33995297 DOI: 10.3389/fmicb.2021.638609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Beattie SR, Krysan DJ. A Unique Dual-Readout High-Throughput Screening Assay To Identify Antifungal Compounds with Aspergillus fumigatus. mSphere 2021;6:e0053921. [PMID: 34406854 DOI: 10.1128/mSphere.00539-21] [Reference Citation Analysis]
13 Dal Mas C, Rossato L, Shimizu T, Oliveira EB, da Silva Junior PI, Meis JF, Colombo AL, Hayashi MAF. Effects of the Natural Peptide Crotamine from a South American Rattlesnake on Candida auris, an Emergent Multidrug Antifungal Resistant Human Pathogen. Biomolecules 2019;9:E205. [PMID: 31141959 DOI: 10.3390/biom9060205] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
14 Wall G, Chen E, Hull MV, Lopez-Ribot JL. Screening the CALIBR ReFRAME Library in Search for Inhibitors of Candida auris Biofilm Formation. Front Cell Infect Microbiol 2020;10:597931. [PMID: 33324579 DOI: 10.3389/fcimb.2020.597931] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
15 Kovács R, Nagy F, Tóth Z, Forgács L, Tóth L, Váradi G, Tóth GK, Vadászi K, Borman AM, Majoros L, Galgóczy L. The Neosartorya fischeri Antifungal Protein 2 (NFAP2): A New Potential Weapon against Multidrug-Resistant Candida auris Biofilms. Int J Mol Sci 2021;22:E771. [PMID: 33466640 DOI: 10.3390/ijms22020771] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
16 Simm C, Weerasinghe H, Thomas DR, Harrison PF, Newton HJ, Beilharz TH, Traven A. Disruption of Iron Homeostasis and Mitochondrial Metabolism Are Promising Targets to Inhibit Candida auris. Microbiol Spectr 2022;:e0010022. [PMID: 35412372 DOI: 10.1128/spectrum.00100-22] [Reference Citation Analysis]
17 Wall G, Herrera N, Lopez-Ribot JL. Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box. J Fungi (Basel) 2019;5:E92. [PMID: 31581540 DOI: 10.3390/jof5040092] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 6.7] [Reference Citation Analysis]
18 Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp. Antimicrob Agents Chemother 2020;64:e01921-19. [PMID: 31988099 DOI: 10.1128/AAC.01921-19] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
19 Lara HH, Lopez-Ribot JL. Inhibition of Mixed Biofilms of Candida albicans and Methicillin-Resistant Staphylococcus aureus by Positively Charged Silver Nanoparticles and Functionalized Silicone Elastomers. Pathogens 2020;9:E784. [PMID: 32992727 DOI: 10.3390/pathogens9100784] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
20 Scorzoni L, Fuchs BB, Junqueira JC, Mylonakis E. Current and promising pharmacotherapeutic options for candidiasis. Expert Opin Pharmacother 2021;22:867-87. [PMID: 33538201 DOI: 10.1080/14656566.2021.1873951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Vila T, Montelongo-Jauregui D, Ahmed H, Puthran T, Sultan AS, Jabra-Rizk MA. Comparative Evaluations of the Pathogenesis of Candida auris Phenotypes and Candida albicans Using Clinically Relevant Murine Models of Infections. mSphere 2020;5:e00760-20. [PMID: 32759340 DOI: 10.1128/mSphere.00760-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Cheng YS, Roma JS, Shen M, Mota Fernandes C, Tsang PS, Forbes HE, Boshoff H, Lazzarini C, Del Poeta M, Zheng W, Williamson PR. Identification of Antifungal Compounds against Multidrug-Resistant Candida auris Utilizing a High-Throughput Drug-Repurposing Screen. Antimicrob Agents Chemother 2021;65:e01305-20. [PMID: 33468482 DOI: 10.1128/AAC.01305-20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 de Moraes DC. Current scenario of the search for new antifungal agents to treat Candida auris infections: An integrative review. J Mycol Med 2021;32:101232. [PMID: 34883404 DOI: 10.1016/j.mycmed.2021.101232] [Reference Citation Analysis]
24 Kean R, Ramage G. Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris. mSphere 2019;4:e00458-19. [PMID: 31366705 DOI: 10.1128/mSphere.00458-19] [Cited by in Crossref: 40] [Cited by in F6Publishing: 23] [Article Influence: 13.3] [Reference Citation Analysis]
25 Wen W, Cao H, Huang Y, Tu J, Wan C, Wan J, Han X, Chen H, Liu J, Rao L, Su C, Peng C, Sheng C, Ren Y. Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of Candidiasis. J Med Chem 2022. [PMID: 35099959 DOI: 10.1021/acs.jmedchem.1c02102] [Reference Citation Analysis]
26 Boyd NK, Lee GC, Teng C, Frei CR. In vitro activity of non-antibiotic drugs against Staphylococcus aureus clinical strains. J Glob Antimicrob Resist 2021;27:167-71. [PMID: 34560306 DOI: 10.1016/j.jgar.2021.09.003] [Reference Citation Analysis]
27 Santi C, Scimmi C, Sancineto L. Ebselen and Analogues: Pharmacological Properties and Synthetic Strategies for Their Preparation. Molecules 2021;26:4230. [PMID: 34299505 DOI: 10.3390/molecules26144230] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Yaakoub H, Staerck C, Mina S, Godon C, Fleury M, Bouchara JP, Calenda A. Repurposing of auranofin and honokiol as antifungals against Scedosporium species and the related fungus Lomentospora prolificans. Virulence 2021;12:1076-90. [PMID: 33825667 DOI: 10.1080/21505594.2021.1909266] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Wall G, Lopez-Ribot JL. Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. Antibiotics (Basel) 2020;9:E445. [PMID: 32722455 DOI: 10.3390/antibiotics9080445] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
30 Peyclit L, Yousfi H, Rolain JM, Bittar F. Drug Repurposing in Medical Mycology: Identification of Compounds as Potential Antifungals to Overcome the Emergence of Multidrug-Resistant Fungi. Pharmaceuticals (Basel) 2021;14:488. [PMID: 34065420 DOI: 10.3390/ph14050488] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]